Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2020

Related Party Transactions [Abstract]

Schedule of Incurred Expenses of Minority Shareholders

During the years ended December 31, 2020 and 2019 the Company incurred the following expenses with respect to the minority shareholders of Lucid Diagnostics Inc.:

	For the year ended December 31,
	2020		2019
CWRU License Agreement – reimbursement of patent legal fees	$	250	$	200
CWRU License Agreement Amendment fee		100		75
EsoCheck devices provided to CWRU		15		—
Fees - Physician Inventors’ consulting agreements		83		110
Stock-based compensation expense - Physician Inventors’ stock option grants		23		57
Total	$	471	$	442